Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: Potent targets for cancer stem cell therapy

International Journal of Hyperthermia

Volumn 29, Issue 5, 2013, Pages 436-441

  Torigoe, Toshihiko ^a   Hirohashi, Yoshihiko ^a   Yasuda, Kazuyo ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer stem cells; Heat shock protein; HSF1; Stress response; Testis antigen

Indexed keywords

ABC TRANSPORTER; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; SELENOPROTEIN; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR NRF2;

APOPTOSIS; ARTICLE; CANCER STEM CELL; CANCER THERAPY; CELL STRESS; DETOXIFICATION; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HYPERTHERMIC THERAPY; LONGEVITY; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; RECURRENT DISEASE; SPERMATOGENESIS; STRESS; TUMOR RECURRENCE;

EID: 84881142527     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2013.814809     Document Type: Article

References (60)

1. Zhang F, Song C, Ma Y, Tang L, Xu Y, Wang H. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression. Int J Mol Med 2011;28:365-71.
2. Shahi P, Seethammagari MR, Valdez JM, Xin L, Spencer DM. Wnt and Notch pathways have interrelated opposing roles on prostate progenitor cell proliferation and differentiation. Stem Cells 2011; 29:678-88.
3. Li G, Zhao F, Cui Y. Proteomics using mammospheres as a model system to identify proteins deregulated in breast cancer stem cells. Curr Mol Med 2013;13:459-63.
4. Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L, et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PloS One 2008;3:e2428.
5. Hsu CS, Tung CY, Yang CY, Lin CH. Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620. PloS One 2013;8:e61133.
6. Abdullah LN, Chow EK. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med 2013;2:3.
7. Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, et al. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J Natl Cancer Inst 2010;102:1637-52.
8. Achuthan S, Santhoshkumar TR, Prabhakar J, Nair SA, Pillai MR. Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species. J Biol Chem 2011;286:37813-29.
9. Foster BA, Gangavarapu KJ, Mathew G, Azabdaftari G, Morrison CD, Miller A, et al. Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme. PloS One 2013;8:e55062.
10. Nakatsugawa M, Takahashi A, Hirohashi Y, Torigoe T, Inoda S, Murase M, et al. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Lab Invest 2011;91:1796-804.
11. Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N, et al. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay. J Urol 2012;188:294-9.
12. Nishizawa S, Hirohashi Y, Torigoe T, Takahashi A, Tamura Y, Mori T, et al. HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res 2012;72:2844-54.
13. Nishida S, Hirohashi Y, Torigoe T, Inoue R, Kitamura H, Tanaka T, et al. Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor. Cancer Sci 2013;104: 431-6.
14. Morita R, Hirohashi Y, Suzuki H, Takahashi A, Tamura Y, Kanaseki T, et al. DNA methyltransferase 1 is essential for initiation of the colon cancers. Exp Mol Pathol 2013;94:322-9.
15. Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002;99:507-12. (Pubitemid 34533085)
16. Yamada R, Takahashi A, Torigoe T, Morita R, Tamura Y, Tsukahara T, et al. Preferential expression of cancer/testis genes in cancer stem-like cells: Proposal of a novel sub-category, cancer/testis/stem gene. Tissue Antigens 2013;81:428-34.
17. Caballero OL, Chen YT. Cancer/testis (CT) antigens: Potential targets for immunotherapy. Cancer Sci 2009;100:2014-21.
18. Lage H, Jordan A, Scholz R, Dietel M. Thermosensitivity of multidrug-resistant human gastric and pancreatic carcinoma cells. Int J Hyperthermia 2000;16:291-303. (Pubitemid 30611726)
19. Caldera V, Mellai M, Annovazzi L, Monzeglio O, Piazzi A, Schiffer D. MGMT hypermethylation and MDR system in glioblastoma cancer stem cells. Cancer Genomics Proteomics 2012;9:171-8.
20. Vukovic J, Bedin AS, Bartlett PF, Osborne GW. A novel fluorescent reporter CDy1 enriches for neural stem cells derived from the murine brain. Stem Cells Dev 2013; epub ahead of print. DOI: 10.1089/scd.2012.0660.
21. Hawley TS, Riz I, Yang W, Wakabayashi Y, Depalma L, Chang YT, et al. Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1. Am J Hematol 2013;88:265-72.
22. Gangavarpu KJ, Huss WJ. Isolation and applications of prostate side population cells based on dye cycle violet efflux. Curr Protoc Toxicol 2011;22:22.
23. Saini V, Hose CD, Monks A, Nagashima K, Han B, Newton DL, et al. Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma. PloS One 2012;7:e41401.
24. Hsu LC, Chang WC, Hoffmann I, Duester G. Molecular analysis of two closely related mouse aldehyde dehydrogenase genes: Identification of a role for Aldh1, but not Aldh-pb, in the biosynthesis of retinoic acid. Biochem J 1999;339:387-95. (Pubitemid 29209970)
25. Rhinn M, Dolle P. Retinoic acid signalling during development. Development (Cambridge) 2012;139:843-58.
26. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R, et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006;24:975-85. (Pubitemid 44464730)
27. Ikawa M, Impraim CC, Wang G, Yoshida A. Isolation and characterization of aldehyde dehydrogenase isozymes from usual and atypical human livers. J Biol Chem 1983;258:6282-7. (Pubitemid 13106804)
28. Hellsten R, Johansson M, Dahlman A, Sterner O, Bjartell A. Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells. PloS One 2011;6:e22118.
29. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-67. (Pubitemid 350056407)
30. Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, et al. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. Cancer Res 2011;71:7226-37.
31. Ucar D, Cogle CR, Zucali JR, Ostmark B, Scott EW, Zori R, et al. Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact 2009;178:48-55.
32. Wei L, Liu TT, Wang HH, Hong HM, Yu AL, Feng HP, et al. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-kappaB. Breast Cancer Res 2011;13:R101.
33. Sreerama L, Sladek NE. Cellular levels of class 1 and class 3 aldehyde dehydrogenases and certain other drug-metabolizing enzymes in human breast malignancies. Clin Cancer Res 1997;3: 1901-14. (Pubitemid 27505115)
34. Bohren KM, Bullock B, Wermuth B, Gabbay KH. The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Biol Chem 1989;264: 9547-51.
35. Seo DC, Sung JM, Cho HJ, Yi H, Seo KH, Choi IS, et al. Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer 2007;6:75.
36. Nomura M, Fukuda T, Fujii K, Kawamura T, Tojo H, Kihara M, et al. Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study. J Clin Bioinforma 2011;1:23.
37. Ahmed MM, Wang T, Luo Y, Ye S, Wu Q, Guo Z, et al. Aldo-keto reductase-7A protects liver cells and tissues from acetaminopheninduced oxidative stress and hepatotoxicity. Hepatology 2011;54: 1322-32.
38. Desmond JC, Mountford JC, Drayson MT, Walker EA, Hewison M, Ride JP, et al. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res 2003;63:505-12. (Pubitemid 36152514)
39. Ruiz FX, Porte S, Pares X, Farres J. Biological role of aldo-keto reductases in retinoic acid biosynthesis and signaling. Frontiers Pharmacol 2012;3:58.
40. Jung KA, Choi BH, Nam CW, Song M, Kim ST, Lee JY, et al. Identification of aldo-keto reductases as NRF2-target marker genes in human cells. Toxicol Lett 2013;218:39-49.
41. Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 2009;284:13291-5.
42. Tsai JJ, Dudakov JA, Takahashi K, Shieh JH, Velardi E, Holland AM, et al. Nrf2 regulates haematopoietic stem cell function. Nat Cell Biol 2013;15:309-16.
43. Kim HY, Gladyshev VN. Methionine sulfoxide reductases: Selenoprotein forms and roles in antioxidant protein repair in mammals. Biochem J 2007;407:321-9. (Pubitemid 350058466)
44. Lee BC, Dikiy A, Kim HY, Gladyshev VN. Functions and evolution of selenoprotein methionine sulfoxide reductases. Biochim Biophys Acta 2009;1790:1471-7.
45. Ferguson LR, Karunasinghe N, Zhu S, Wang AH. Selenium and its role in the maintenance of genomic stability. Mutat Res 2012;733: 100-10.
46. Sedding DG. FoxO transcription factors in oxidative stress response and ageing - A new fork on the way to longevity? Biol Chem 2008; 389:279-83.
47. Zhang X, Rielland M, Yalcin S, Ghaffari S. Regulation and function of FoxO transcription factors in normal and cancer stem cells: What have we learned? Curr Drug Targets 2011;12:1267-83.
48. Eijkelenboom A, Burgering BM. FOXOs: Signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 2013;14:83-97.
49. Sunayama J, Sato A, Matsuda K, Tachibana K, Watanabe E, Seino S, et al. FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity. Stem Cells 2011;29:1327-37.
50. Calderwood SK. Heat shock proteins in breast cancer progression -A suitable case for treatment? Int J Hyperthermia 2010;26:681-5.
51. Noonan EJ, Place RF, Giardina C, Hightower LE. Hsp70B0 regulation and function. Cell Stress Chaperones 2007;12:219-29.
52. Le Masson F, Christians E. HSFs and regulation of Hsp70.1 (HSPA1B) in oocytes and preimplantation embryos: New insights brought by transgenic and knockout mouse models. Cell Stress Chaperones 2011;16:275-85.
53. Wilkerson DC, Murphy LA, Sarge KD. Interaction of HSF1 and HSF2 with the HSPA1B promoter in mouse epididymal spermatozoa. Biol Reprod 2008;79:283-8.
54. Mendillo ML, Santagata S, Koeva M, Bell GW, Hu R, Tamimi RM, et al. HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell 2012;150: 549-62.
55. Newman B, Liu Y, Lee HF, Sun D, Wang Y. HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells. Cancer Res 2012; 72:4551-61.
56. Whitesell L, Lindquist S. Inhibiting the transcription factor HSF1 as an anticancer strategy. Expert Opin Therapeut Targets 2009;13: 469-78.
57. Wierenga PK, Konings AW. Effect of a hyperthermic treatment on the pluripotent haemopoietic stem cell in normal and anaemic mice. Int J Hyperthermia 1990;6:793-800. (Pubitemid 20269647)
58. Hirohashi Y, Torigoe T, Inoda S, Takahashi A, Morita R, Nishizawa S, et al. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells. Immunotherapy 2010;2:201-11.
59. Cappell KM, Sinnott R, Taus P, Maxfield K, Scarbrough M, Whitehurst AW. Multiple cancer testis antigens function to support tumor cell mitotic fidelity. Mol Cell Biol 2012;32:4131-40.
60. Chou SD, Prince T, Gong J, Calderwood SK. mTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesis. PloS One 2012;7:e39679.